Target (CBDY) Long-Term Investments (2020 - 2023)
Target (CBDY) reported Long-Term Investments of $1.3 million for Q1 2023, down 39.04% year-over-year from $2.1 million in Q1 2022, and up 63.79% quarter-over-quarter from $775577.0 in Q4 2022.
Target (CBDY) Long-Term Investments (2020 - 2023) Analysis & Trends
Target (CBDY) has 4 years of Long-Term Investments data on file, last reported at $1.3 million in Q1 2023.
- Long-Term Investments for Q1 2023 came in at $1.3 million, down 39.04% year-over-year; the trailing twelve-month figure through Mar 2023 was $1.3 million (down 39.04% YoY), and the FY2022 annual result was $775577.0, down 58.53% from the prior year.
- Long-Term Investments rose to $1.3 million in Q1 2023 per CBDY's latest filing, from $775577.0 in the prior quarter.
- Over five years, Long-Term Investments peaked at $2.1 million in Q1 2022 and troughed at $103693.0 in Q2 2020.
- A 4-year average of $1.0 million and a median of $960057.0 in 2021 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2021 and 2022: Long-Term Investments jumped 1428.66% in 2021, then slumped 64.77% in 2022.
- A 4-year view of Long-Term Investments shows it stood at $721156.0 in 2020, then soared by 159.32% to $1.9 million in 2021, then plunged by 58.53% to $775577.0 in 2022, then soared by 63.79% to $1.3 million in 2023.
- Business Quant data shows CBDY's Long-Term Investments at $1.3 million in Q1 2023, $775577.0 in Q4 2022, and $569194.0 in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 1.32 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 26.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.90 Mn |
| 10 | Target | - | - | 191,787.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 1.27 Mn |
| Dec 31, 2022 | 775,577.00 |
| Sep 30, 2022 | 569,194.00 |
| Jun 30, 2022 | 665,540.00 |
| Mar 31, 2022 | 2.08 Mn |
| Dec 31, 2021 | 1.87 Mn |
| Sep 30, 2021 | 1.62 Mn |
| Jun 30, 2021 | 1.59 Mn |
| Mar 31, 2021 | 1.14 Mn |
| Dec 31, 2020 | 721,156.00 |
| Sep 30, 2020 | 161,818.00 |
| Jun 30, 2020 | 103,693.00 |